Shoppers Drug Mart billed the Ontario government’s MedsCheck program $81.2 million for medication reviews over two years, a significant increase from the previous six years combined. Current and former pharmacists reported facing corporate pressure to meet review targets, raising concerns about the ethics of prioritizing corporate goals over patient care. Overall, Shoppers accounted for 77% of the $293.2 million billed by eight pharmacy chains since 2013, highlighting a troubling trend in healthcare corporatization. The company defends its practices as necessary amid rising chronic disease rates and a primary care crisis.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
